Chiral phosphine ligands

17261-28-8, 2-(Diphenylphosphino)benzoic acid is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

17261-28-8, A mixture of DCMOH (156.2 mg, 0.5 mmol), 2-(diphenylphosphino)benzoic acid (183.8 mg, 0.6 mmol), N,N?-dicyclohexylcarbodiimide(288.9 mg, 1.4 mmol) and 4-dimethylaminopyridine (61.1 mg, 0.5 mmol) in anhydrousdichloromethane was stirred at room temperature for 12 h.The residue was filtrated, washed with brine, and extractedwith dichloromethane. The organic layer was dried overanhydrous Na2SO4 and concentrated. The residue was purifiedby silica gel chromatography with dichloromethane/methanol (15:1, v/v) to give DCMHNO as a brown solid(195 mg, 65%). 1H NMR (400 MHz, CDCl3) delta 8.91 (dd, J1=8.4 Hz, J2=1.2 Hz, 1H), 8.31-8.22 (m, 1H), 7.76-7.72 (m,1H), 7.63-7.52 (m, 4H), 7.50-7.42 (m, 3H), 7.41-7.27 (m,10H), 7.06-6.98 (m, 3H), 6.86 (s, 1H), 6.75 (d, J=15.9 Hz,1H). 13C NMR (101 MHz, CDCl3) delta 164.94, 157.26, 152.81,152.32, 152.21, 141.67, 141.39, 137.85, 137.55, 137.44,134.71, 134.52, 134.16, 133.95, 132.76, 132.28, 131.40,128.96, 128.86, 128.65, 128.58, 128.39, 126.02, 125.84,122.49, 118.79, 118.63, 117.84, 116.71, 115.62, 106.98,63.05. HRMS (MALDI-TOF): m/z: [M+K]+ calcd. forC39H25KN2O3P+: 639.1234; found: 639.1444. m.p.232-234 C.

As the paragraph descriping shows that 17261-28-8 is playing an increasingly important role.

Reference£º
Article; Wang, Jianguo; Zhu, Wenping; Li, Chunbin; Zhang, Pengfei; Jiang, Guoyu; Niu, Guangle; Tang, Ben Zhong; Science China Chemistry; (2019);,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.855-38-9,Tris(4-methoxyphenyl)phosphine,as a common compound, the synthetic route is as follows.,855-38-9

EXAMPLE 20 N-(2,2,2-Trifluoroethyl)-6-[1-methyl-3-(trifluoromethyl)pyrazol-5-yloxy]pyridine-2-carboxamide Analogously to Example 14, 1.39 g (5 mmol) of 2-chloro-6-[1-methyl-3-(trifluoromethyl)-pyrazol-5-yloxy]pyridine, 0.75 g (7.57 mmol, 98 percent content) of 2,2,2-trifluoroethylamine, 0.80 g (7.55 mmol) of anhydrous sodium carbonate, 5.6 mg (25 mumol) of palladium(II) acetate and 88 mg (0.25 mmol) of tris(4-methoxyphenyl)phosphine in 20 ml of methylcyclohexane were reacted under a CO pressure of 21 bar. The yield was 0.96 g (75.4 percent) of a white solid. The melting point was 135.8 to 136.3 C. (from methylcyclohexane). Other data concerning the product was: MS; m/z: 368 (M+); 242 (100 percent) 1 H NMR (CDCl3): delta=3.82 (s, 3H); 4.05 (m, 2H); 6.29 (s, 1H); 7.27 (dt, J=8.1/0.6 Hz, 1H); 7.64 (br. s, 1H); 8.01 (dd, J=7.3/0.5 Hz, 1H); 8.07 (d, J=7.3 Hz, 1H).

The synthetic route of 855-38-9 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Lonza AG; US5900484; (1999); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

787618-22-8, Dicyclohexyl(2′,6′-diisopropoxy-[1,1′-biphenyl]-2-yl)phosphine is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

General procedure: After purging with argon, a scintillation vial (10 mL), which was equipped with amagnetic stir bar, was charged with RuPhos (1 equiv), the aryl containing drug or the drugderivative, and [(L5-COD)Pd(CT-iSi~1fe3)] (l. l equiv) dissolved in tetrahydrofuran (THF,0.2 M). The closed vial was purged with argon and stined for 16 h. The resulting precipitatewas tlltered, washed with pentane (3 X 3 mL), and dried under reduced pressure to afford theoxidative addition complex (Figure 3). Other potential aryl containing drugs or drugderivatives are shown in Figure 4., 787618-22-8

The synthetic route of 787618-22-8 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; MASSACHUSETTS INSTITUTE OF TECHNOLOGY; BUCHWALD, Stephen, L.; PENTELUTE, Bradley, L.; ZHANG, Chi; (170 pag.)WO2017/151910; (2017); A2;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.18437-78-0,Tris(4-fluorophenyl)phosphine,as a common compound, the synthetic route is as follows.

General procedure: Complex 1 was synthesized by the simultaneous and dropwise addition of tris-(4-fluorophenyl)phosphine(0.316 g, 1 mmol) in acetone and sodium 4-benzylpiperazine-1-carbodithioate (0.274 g, 1 mmol)in methanol to a methanolic suspension of palladium(II) chloride (0.177 g, 1 mmol). The reaction mixturewas refluxed for 5 h with constant stirring. The resulting orange-colored solution was filtered androtary evaporated to obtained orange solid (scheme 1). It was dried and re-dissolved in chloroform,and on slow evaporation needle-like crystals were obtained. Complexes 2 and 3 were synthesized bythe same method (scheme 1).

18437-78-0, The synthetic route of 18437-78-0 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Khan, Shahan Zeb; Amir, Muhammad Kashif; Abbasi, Rashda; Tahir, Muhammad Nawaz; Zia-ur-Rehman; Journal of Coordination Chemistry; vol. 69; 20; (2016); p. 2999 – 3009;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50777-76-9,2-(Diphenylphosphino)benzaldehyde,as a common compound, the synthetic route is as follows.

50777-76-9, 2-(Diphenylphosphino)benzaldehyde (2.09 g, 7.20 mmol, 1.0 equiv.) and mesitylamine (1.01 g,7.44 mmol, 1.03 mmol) were dissolved in 40 mL toluene. The orange solution was heated to 135 for 20 h under a dropping funnel filled with molecular sieves. Evaporating the solvent in vacuo yielded the product as a yellow solid, which was used in following syntheses without further purication (2.60 g, 6.38 mmol, 89 percent).

The synthetic route of 50777-76-9 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Vasilenko, Vladislav; Roth, Torsten; Blasius, Clemens K.; Intorp, Sebastian N.; Wadepohl, Hubert; Gade, Lutz H.; Beilstein Journal of Organic Chemistry; vol. 12; (2016); p. 846 – 853;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.63995-70-0,Sodium 3,3′,3”-phosphinetriyltribenzenesulfonate,as a common compound, the synthetic route is as follows.,63995-70-0

General procedure: Palladium complexes were synthetized according to a modified literature procedure [27].Pd(PPh3)4 (103 mg, 0.089 mmol.) was dissolved in 2 g of degassed toluene into a Schlenk tube under nitrogen. The corresponding phosphane (1.5 equiv., 0.133 mmol) was dissolved in 2 g of D2O and cannulated onto the palladium solution. The mixture was stirred for 30 min at room temperature. After decantation, the organic phase was removed and a new degassed Pd(PPh3)4 solution was added to the previous aqueous solution which underwent again a 30 min stirring period to ensure an optimal extraction of the palladium by the hydrosoluble ligand. After decantation, the aqueous phase was recovered. The obtained PdLn (n = 2, 3 or 4) solution was then used for the 31P{1H} NMRstudy. The previous solution usually contained a small excess of free ligand. Study in the presence of RAME-beta-CD was conducted as follow: to 1 mL of the above solution was introduced under nitrogen the required amount of RAME-beta-CD. After 15 min of stirring, the solution was transferred via cannula into a nitrogen pressurized 5 mm NMR tube.

63995-70-0 Sodium 3,3′,3”-phosphinetriyltribenzenesulfonate 6099338, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Article; Ferreira, Michel; Bricout, Herve; Tilloy, Sebastien; Monflier, Eric; Molecules; vol. 22; 1; (2017);,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1079-66-9,Chlorodiphenylphosphine,as a common compound, the synthetic route is as follows.

If the process is carried out in such a manner that the mixture is brought to room temperature after completion of the dropwise addition of chloro(diphenyl)phosphine, then kept under reflux for 12 hours and then worked up as above after cooling, 195 g of ethyl diphenylphosphinite are obtained. This corresponds to a yield of 94% of theory.

1079-66-9, As the paragraph descriping shows that 1079-66-9 is playing an increasingly important role.

Reference£º
Patent; Hoechst Aktiengesellschaft; US5705669; (1998); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1608-26-0,N,N,N’,N’,N”,N”-Hexamethylphosphinetriamine,as a common compound, the synthetic route is as follows.

Trisdimethylaminophosphine 1 (1 mmol)was added to a solution of isatin imine 2a (1 mmol) in dry toluene (30mL), and the resulting mixture was stirring at room temperature for 4 h (TLC) in the presence of atmospheric moisture.[24] After evaporation of the volatile material under reduced pressure, the residue was subjected to silica-gel column chromatography to give the product 4a., 1608-26-0

The synthetic route of 1608-26-0 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Arsanious, Mona Hizkial Nasr; Maigali, Soher Said; Synthetic Communications; vol. 44; 2; (2014); p. 202 – 214;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

5931-53-3,5931-53-3, Diphenyl(o-tolyl)phosphine is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

General procedure: Equimolar amounts of KSeCN (5.8 mg, 0.04 mmol) andeither diphenyl(ortho-tolyl)phosphane (11.1 mg, 0.04 mmol)or dicyclohexyl(ortho-tolyl)phosphane (11.5 mg, 0.04 mmol)were dissolved in the minimum amount of MeOH (10 ml). TheKSeCN solution was added dropwise (over a period of 5 min)to the phosphane solution with stirring at room temperature.Slow evaporation of the solvent afforded the title compoundsas colourless crystals suitable for single-crystal X-ray studies.Analytical data for I, 31P {H} NMR (CDCl3, 161.99 MHz):32.03 [t, 1J(31P-77Se) = 714 Hz]

The synthetic route of 5931-53-3 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Davis, Wade L.; Muller, Alfred; Acta Crystallographica Section C: Structural Chemistry; vol. 75; (2019); p. 1310 – 1318;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

146960-90-9, 1,1′-Bis(dicyclohexylphosphino)ferrocene is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

537 mg (1.73 mmol) of Rh(COD)(acac) was mixed with 10ml of MEK in a small Schlenk flask. To the resulting slurry was added by syringe 0.23 ml of 48% aqueous tetrafluoroboric acid (1.76 mmol) over a period of 2 minutes, resulting in a red solution. After 10 minutes, 0.1 ml (0.83 mmol) of 1 ,5-cyclooctadiene was added by syringe. The brown red slurry was stirred for 20 minutes and then 1g of 1,1′-bis-(dicyclohexylphosphino)ferrocene (DCyPFC) (1.73 mmol) was added. A clear red solution resulted. The stirred solution was then reduced by evaporating MEK solvent. Removal of the ketone solvent was continued until a slurry of the cationic complex in about 3 ml of residual solvent was obtained. To this slurry was added 3 ml of ethanol. The resulting orange slurry was degassed and stripped to about 4 ml of ethanol/MEK. The remaining thick slurry was stirred at room temperature for 1 hour before being filtered and washed with 2×2 ml of cold ethano.. After drying overnight (1 mbar, 2O0C), gave 1.44 g of complex [Rh cod DCyPFC] BF4 , Yield = 95.4 % (1.65 mmol)., 146960-90-9

The synthetic route of 146960-90-9 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; JOHNSON MATTHEY PUBLIC LIMITED COMPANY; NEDDEN, Hans Guenter; WO2010/1173; (2010); A1;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate